Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
68,768,829
-
Share change
-
+3,489,992
-
Total reported value
-
$3,157,894,888
-
Put/Call ratio
-
49%
-
Price per share
-
$45.92
-
Number of holders
-
196
-
Value change
-
+$157,182,806
-
Number of buys
-
99
-
Number of sells
-
111
Institutional Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q2 2015
As of 30 Jun 2015,
IMPAX LABORATORIES INC - COM (IPXL) was held by
196 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,768,829 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Hound Partners, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Pennant Capital Management, LLC, Invesco Ltd., ARAVT GLOBAL LLC, STATE STREET CORP, and Slate Path Capital LP.
This page lists
196
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.